The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
The American Lung Association is raising awareness about updated pneumococcal vaccine guidelines, emphasizing prevention and patient education for at-risk populations.
Bridging to Warfarin with Heparin in Atrial Fibrillation Isn't Necessary, May Be Harmful
October 10th 2016Little information exists regarding the benefit of bridging warfarin among patients with atrial fibrillation. The best available evidence suggests that this common practice may increase the risk of bleeding without providing any efficacy benefit.
Read More
FDA Approves New Continuous Glucose Monitoring System for Diabetes
October 7th 2016The FDA has approved a new continuous glucose monitoring (CGM) system designed to provide health care professionals with clear, visual snapshots of glucose levels, trends, and patterns in patients with diabetes at a lower cost than other CGM devices on the market.
Read More
Improvements to opioid prescribing, increasing the use of naloxone to reverse opioid overdose and expanding the use of medication-assisted treatment (MAT) for opioid-use disorders were among the many suggestions to come out of the Academy of Managed Care Pharmacy (AMCP) Foundation 6th Annual Research Symposium, Balancing Access and Use of Opioid Therapy."
Read More
Connecticut Man Charged for Forging Numerous Controlled Substance Prescriptions
October 5th 2016A Connecticut man sentenced to 6 years in prison last year for conspiracy to pass 2 forged prescriptions is now being accused of passing more fraudulent prescriptions successfully and netting more than 1000 tablets of medication.
Read More
Stelara Biologic Approved for Crohn's Disease
October 4th 2016The FDA recently approved Janssen's ustekinumab (Stelara) for the treatment of moderate to severe active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necrosis factor (TNF) blocker, as well as those who failed or were intolerant to treatment with one or more TNF blockers.
Read More